FIDVAXI
LIVE

Serial Number

79352782

Owner

Genexine, Inc.

Attorney

LEIGH ANN LINDQUIST

Filing Date

Sep 1, 2022

Add to watchlist:

No watchlists yet
View on USPTO

FIDVAXI Trademark

Serial Number: 79352782 • Registration: 7220670

FIDVAXI is a trademark filed by Genexine, Inc. on September 1, 2022. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Genexine, Inc. (16 trademarks)

(Magokdong, Bio Innovation Park) 172,

Entity Type: 98

Trademark Details

Filing Date

September 1, 2022

Registration Date

November 21, 2023

Published for Opposition

September 5, 2023

Goods & Services

Research and development of vaccines and medicines; development of new cell therapy products for others; drug discovery services; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; Pharmaceutical drug development services; inspection of pharmaceuticals; development of pharmaceutical preparations and medicines; laboratory research in the field of pharmaceuticals; consultancy relating to pharmaceutical research and development; pharmaceutical research and development; research on the subject of pharmaceuticals; clinical research in the field of medicine; consultancy pertaining to pharmacology; medical laboratories; medical research laboratory services; medical research laboratory services for predicting disease; medicine research; testing of pharmaceuticals

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Feb 7, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 18, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 27, 2024 FICS
FINAL DISPOSITION PROCESSED
Feb 27, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 21, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 21, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 21, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 5, 2023 NPUB
PUBLISHED FOR OPPOSITION
Sep 5, 2023 PUBO
NOTIFICATION PROCESSED BY IB
Sep 4, 2023 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 16, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 16, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 16, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 28, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 6, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 6, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 6, 2023 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 13, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jun 13, 2023 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 13, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 13, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 13, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 13, 2023 COAR
REFUSAL PROCESSED BY IB
Feb 8, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 13, 2023 RFCS
REFUSAL PROCESSED BY MPU
Jan 13, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 3, 2022 RFCR
NON-FINAL ACTION WRITTEN
Nov 2, 2022 CNRT
ASSIGNED TO EXAMINER
Nov 2, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 25, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 21, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 20, 2022 REPR